Patents by Inventor Tomi K. Sawyer

Tomi K. Sawyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040152671
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: November 17, 2003
    Publication date: August 5, 2004
    Applicant: ARIAD Pharmaceuticals, Inc.
    Inventors: Yihan Wang, Chester A. Metcalf, William C. Shakespeare, Tomi K. Sawyer, Regine Bohacek, Rajeswari Sundaramoorthi
  • Patent number: 6713462
    Abstract: The invention relates to compounds of the general formula (and pharmaceutically acceptable derivatives thereof): in which RA, RB, RC, RD, R5, R7, R9, R9a, AK, p, q, r and X are as defined herein, and to their preparation and use.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: March 30, 2004
    Assignee: Ariad Pharmaceuticals, Inc.
    Inventors: Chester A. Metcalf, III, William C. Shakespeare, Tomi K. Sawyer, Yihan Wang, Regine Bohacek, Rajeswari Sundaramoorthi
  • Patent number: 6706699
    Abstract: This invention relates to compounds of the general formula: in which RA, RB, RC and RD are as defined herein, and to their preparation and use.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: March 16, 2004
    Assignee: Ariad Pharmaceuticals, Inc.
    Inventors: Yihan Wang, Chester A. Metcalf, III, William C. Shakespeare, Tomi K. Sawyer, Regine Bohacek, Rajeswari Sundaramoorthi
  • Publication number: 20040002479
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: March 12, 2003
    Publication date: January 1, 2004
    Inventors: Yihan Wang, Tomi K. Sawyer, David L. Berstein
  • Publication number: 20030130234
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: June 21, 2002
    Publication date: July 10, 2003
    Inventors: William C. Shakespeare, Tomi K. Sawyer, Chester A. Metcalf, Yihan Wang, Regine Bohacek
  • Publication number: 20030114486
    Abstract: The invention relates to compounds of the general formula (and pharmaceutically acceptable derivatives thereof): 1
    Type: Application
    Filed: June 21, 2002
    Publication date: June 19, 2003
    Inventors: Chester A. Metcalf, William C. Shakespeare, Tomi K. Sawyer, Yihan Wang, Regine Bohacek
  • Publication number: 20030114467
    Abstract: The invention relates to compounds of the general formula: 1
    Type: Application
    Filed: June 21, 2002
    Publication date: June 19, 2003
    Inventors: William C. Shakespeare, Tomi K. Sawyer, Chester A. Metcalf, Yihan Wang, Regine Bohacek, Rajeswari Sundaramoorthi
  • Patent number: 6576766
    Abstract: This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediate by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to pharmaceutic compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds. The compounds are of formula (1) as defined herein.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: June 10, 2003
    Assignee: Ariad Pharmaceuticals, Inc.
    Inventors: Manfred Weigele, Regine Bohacek, Virginia A. Jacobsen, Karina Macek, Michael G. Yang, Noriyuki H. Kawahata, Rajeswari Sundaramoorthi, Yihan Wang, Craig S. Takeuchi, George P. Luke, Chester A. Metcalf, III, William C. Shakespeare, Tomi K. Sawyer
  • Publication number: 20030105115
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: June 21, 2002
    Publication date: June 5, 2003
    Inventors: Chester A. Metcalf, William C. Shakespeare, Tomi K. Sawyer, Yihan Wang, Regine Bohacek
  • Publication number: 20030105065
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: June 21, 2002
    Publication date: June 5, 2003
    Inventors: Yihan Wang, Chester A. Metcalf, William C. Shakespeare, Tomi K. Sawyer, Regine Bohacek
  • Patent number: 6573295
    Abstract: This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to pharmaceutical compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds. The compounds are of the formula as defined herein.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: June 3, 2003
    Assignee: Ariad Pharmaceuticals, Inc.
    Inventors: William C. Shakespeare, Michael G. Yang, Rajeswari Sundaramoorthi, Regine Bohacek, Charles Joseph Eyermann, Tomi K. Sawyer
  • Publication number: 20030100572
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: June 21, 2002
    Publication date: May 29, 2003
    Applicant: ARIAD PHARMACEUTICALS,INC.
    Inventors: Chester A. Metcalf, William C. Shakespeare, Tomi K. Sawyer, Yihan Wang, Regine Bohacek
  • Publication number: 20030100573
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: June 21, 2002
    Publication date: May 29, 2003
    Inventors: Yihan Wang, Chester A. Metcalf, William C. Shakespeare, Tomi K. Sawyer, Regine Bohacek
  • Patent number: 6482852
    Abstract: This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to pharmaceutical compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds. The compounds are of the formula as defined herein.
    Type: Grant
    Filed: May 11, 2001
    Date of Patent: November 19, 2002
    Assignee: Ariad Pharmaceuticals, Inc.
    Inventors: William C. Shakespeare, Michael G. Yang, Rajeswari Sundaramoorthi, Regine Bohacek, Charles Joseph Eyermann, Tomi K. Sawyer
  • Publication number: 20020137941
    Abstract: This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to pharmaceutical compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds.
    Type: Application
    Filed: May 11, 2001
    Publication date: September 26, 2002
    Inventors: William C. Shakespeare, Michael G. Yang, Rajeswari Sundaramoorthi, Regine Bohacek, Charles Joseph Eyermann, Tomi K. Sawyer
  • Publication number: 20020132819
    Abstract: Novel purines and uses of these compounds for the treatment of bone related disorders and cancer is disclosed.
    Type: Application
    Filed: December 18, 2000
    Publication date: September 19, 2002
    Inventors: Chester A. Metcalf, Manfred Weigele, Tomi K. Sawyer, Regine Bohacek, William C. Shakespeare, Rajeswari Sundaramoorthi, Yihan Wang, David C. Dalgarno
  • Publication number: 20020103161
    Abstract: The present invention relates to bone-targeting compounds useful for treating a variety of disorders and conditions, e.g., of bone tissue.
    Type: Application
    Filed: December 18, 2000
    Publication date: August 1, 2002
    Inventors: Manfred Weigele, George P. Luke, Tomi K. Sawyer, Regine Bohacek, William C. Shakespeare, Rajeswari Sundaramoorthi, Yihan Wang, David C. Dalgarno, Chester A. Metcalf, Chi B. Vu, Noriyuki H. Kawahata
  • Patent number: 6420384
    Abstract: Compounds and methods of treating or preventing bone disorders including osteoporosis, rheumatoid arthritis, and metastatic bone disease are provided. The inventive compounds comprise a bone targeting moiety and a payload. The payload portion of these inventive compounds inhibit the proton pump of osteoclasts, thereby, reducing bone resorption.
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: July 16, 2002
    Assignee: Ariad Pharmaceuticals, Inc.
    Inventors: Manfred Weigele, David C. Dalgarno, John Iuliucci, Terence P. Keenan, Tomi K. Sawyer
  • Publication number: 20020068721
    Abstract: This invention relates to compounds of the general formula: 1
    Type: Application
    Filed: December 18, 2000
    Publication date: June 6, 2002
    Inventors: Manfred Weigele, Tomi K. Sawyer, Regine Bohacek, William C. Shakespeare, Rajeswari Sundaramoorthi, Yihan Wang, David C. Dalgarno, Chester A. Metcalf
  • Publication number: 20020062031
    Abstract: This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to pharmaceutical compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds.
    Type: Application
    Filed: November 21, 2001
    Publication date: May 23, 2002
    Inventors: William C. Shakespeare, Michael G. Yang, Rajeswari Sundaramoorthi, Regine Bohacek, Charles Joseph Eyermann, Tomi K. Sawyer